Programming Injectable DNA Hydrogels Yields Tumor Microenvironment‐Activatable and Immune‐Instructive Depots for Augmented Chemo‐Immunotherapy

Abstract Injectable hydrogels have attracted increasing attention for promoting systemic antitumor immune response through the co‐delivery of chemotherapeutics and immunomodulators. However, the biosafety and bioactivity of conventional hydrogel depots are often impaired by insufficient possibilitie...

Full description

Bibliographic Details
Published in:	Advanced Science
Main Authors:	Yu Fan, Mengsi Zhan, Junhao Liang, Xingsen Yang, Beibei Zhang, Xiangyang Shi, Yong Hu
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Subjects:	chemo‐immunotherapy DNA hydrogels immune checkpoint blockade immunogenic cell death vaccine adjuvants
Online Access:	https://doi.org/10.1002/advs.202302119

Similar Items

Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis
by: Zhu H, et al.
Published: (2023-06-01)

Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer
by: Yu Liu, et al.
Published: (2025-03-01)

Targeting Hydrogel for Intelligent Recognition and Spatiotemporal Control in Cell‐Based Therapeutics
by: Weilin Hou, et al.
Published: (2024-08-01)

Laser-activatable oxygen self-supplying nanoplatform for efficiently overcoming colorectal cancer resistance by enhanced ferroptosis and alleviated hypoxic microenvironment
by: Hao Jiang, et al.
Published: (2023-09-01)

M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
by: Naisheng Zheng, et al.
Published: (2023-12-01)

Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
by: Jiajia Xiang, et al.
Published: (2023-10-01)

Tumor lysis with LTX-401 creates anticancer immunity
by: Wei Xie, et al.
Published: (2019-07-01)

PENDEKATAN CHEMO-ENTREPRENEURSHIP MENGGUNAKAN FLASH SEBAGAI MEDIA CHEMO-EDUTAINMENT UNTUK MENINGKATKAN HASIL BELAJAR
by: Didik Nugraheni, et al.
Published: (2017-02-01)

<i>In Situ</i> Crosslinked Hydrogel Depot for Sustained Antibody Release Improves Immune Checkpoint Blockade Cancer Immunotherapy
by: Jihoon Kim, et al.
Published: (2021-02-01)

Mitoxantrone‐Encapsulated ZIF‐8 Enhances Chemo‐Immunotherapy via Amplified Immunogenic Cell Death
by: Junhong Li, et al.
Published: (2025-04-01)

Astragalus polysaccharide-based nano-platforms loading PTX to boost chemo-immunotherapy for triple-negative breast cancer with intrinsic GLUT-targeting ability and immunoregulatory activity
by: Jinshuai Lan, et al.
Published: (2025-10-01)

Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
by: Marion Thibaudin, et al.
Published: (2023-12-01)

Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound
by: Jeongjin Lee, et al.
Published: (2022-11-01)

Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
by: Jeongrae Kim, et al.
Published: (2022-02-01)

Dual-responsive supramolecular photodynamic nanomedicine with activatable immunomodulation for enhanced antitumor therapy
by: Siqin He, et al.
Published: (2024-02-01)

Codelivery of apigenin, FdUMP and CD276 antibody synergistic inhibit colorectal cancer by ferroptosis-apoptosis-pyroptosis and CD276 blockade
by: Weiran Cao, et al.
Published: (2025-04-01)

Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
by: Dong H, et al.
Published: (2023-06-01)

All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy
by: Sukyung Song, et al.
Published: (2023-10-01)

Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy
by: Yujeong Moon, et al.
Published: (2024-06-01)

Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade
by: Chi Yan, et al.
Published: (2021-06-01)

A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance
by: Ginette S. Santiago-Sánchez, et al.
Published: (2024-12-01)

Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor
by: Xinlun Dai, et al.
Published: (2023-12-01)

Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
by: Jinseong Kim, et al.
Published: (2024-03-01)

Neighboring Effect‐Initiated Supramolecular Nanocomplex with Sequential Infiltration as Irreversible Apoptosis Inducer for Synergetic Chemo‐Immunotherapy
by: Mengjie Ye, et al.
Published: (2024-10-01)

Molecular Engineering of Electrosprayed Hydrogel Microspheres to Achieve Synergistic Anti‐Tumor Chemo‐Immunotherapy with ACEA Cargo
by: Youming Deng, et al.
Published: (2024-05-01)

Chemically augmented malaria sporozoites display an altered immunogenic profile
by: Nikolas Duszenko, et al.
Published: (2023-08-01)

Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
by: Stefanie R. Mullins, et al.
Published: (2019-09-01)

Remodeling of tumor microenvironment for enhanced tumor chemodynamic/photothermal/chemo-therapy
by: Ying Zhang, et al.
Published: (2022-08-01)

Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
by: Dan Aravot, et al.
Published: (2019-01-01)

Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
by: Xianzhe Yu, et al.
Published: (2023-04-01)

Effects of Adjuvant Respiratory Therapy on Secretion Expectoration and Treatment Adherence in Patients with Head and Neck Cancer Receiving Concurrent Chemo-Radiotherapy
by: Hsiu-Ying Cho, et al.
Published: (2025-07-01)

Tumor acid microenvironment-activated self-targeting & splitting gold nanoassembly for tumor chemo-radiotherapy
by: Xiaomin Li, et al.
Published: (2022-01-01)

Immunotherapy of targeting MDSCs in tumor microenvironment
by: Hongshu Sui, et al.
Published: (2022-09-01)

Beyond Needles: Immunomodulatory Hydrogel-Guided Vaccine Delivery Systems
by: Md Mohosin Rana, et al.
Published: (2024-12-01)

Necroptosis-driven T cell activation promotes IL-6-mediated PD-L1 upregulation in cholangiocarcinoma cells: IL-6 gene signature as a biomarker for chemo-immunotherapy response
by: Thanpisit Lomphithak, et al.
Published: (2025-09-01)

Tumor microenvironment-responsive micelles assembled from a prodrug of mitoxantrone and 1-methyl tryptophan for enhanced chemo-immunotherapy
by: Ru Wang, et al.
Published: (2023-12-01)

Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
by: Yu-Chen Chuang, et al.
Published: (2020-05-01)

Light-triggered polymeric prodrug and nano-assembly for chemo-photodynamic therapy and potentiate immune checkpoint blockade immunotherapy for hepatocellular carcinoma
by: Yang Gao, et al.
Published: (2023-01-01)

PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2016-07-01)

Sulfafurazole dimers potentiate chemo-immunotherapy of low immunogenic breast cancer by preventing the PD-L1 exosomes secretion
by: Zheng Wang, et al.
Published: (2025-05-01)